Palonosetron Hydrochloride | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Palonosetron Hydrochloride
USP

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Palonosetron Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 22 USDMF, 3 JDMF, 9 EU WC, 4 KDMF, 13 NDC API, 24 Listed Suppliers, $ API Reference Price

40 API Suppliers
22 USDMF
3 JDMF
9 EU WC
4 KDMF
13 NDC API
24 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

11 Intermediates Suppliers

11 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

90 FDF Dossiers, 34 FDA Orange Book, 20 Europe, 2 Canada, 6 Australia, 7 South Africa, 21 Listed Dossiers

90 FDF Dossiers
34 FDA Orange Book
20 Europe
2 Canada
6 Australia
7 South Africa
21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 300MG;EQ 0.5MG BASE, SOLUTION;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML), POWDER;INTRAVENOUS - EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL, SOLUTION;INTRAVENOUS - EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML), INJECTABLE;INTRAVENOUS - EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 300MG;EQ 0.5MG BASE
SOLUTION;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
POWDER;INTRAVENOUS - EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL
SOLUTION;INTRAVENOUS - EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML)
INJECTABLE;INTRAVENOUS - EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 15 SPI Pharma, 7 DKSH, 2 Jai Radhe Sales, 3 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 9 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 3 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 6 Kerry, 3 Lonza Capsugel, 9 Microlex e.U, 1 NEWEDGE Overseas, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 22 Roquette, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

49 Fillers, Diluents & Binders, 23 Direct Compression, 18 Lubricants & Glidants, 17 Thickeners and Stabilizers, 17 Disintegrants & Superdisintegrants, 14 Chewable & Orodispersible Aids, 14 Co-Processed Excipients, 14 Taste Masking, 11 Coating Systems & Additives, 11 Parenteral, 11 Film Formers & Plasticizers, 10 Granulation, 8 Empty Capsules, 7 Controlled & Modified Release, 3 Emulsifying Agents, 3 API Stability Enhancers, 2 Solubilizers, 2 Coloring Agents, 2 Rheology Modifiers, 1 Topical, 1 Soft Gelatin

49 Fillers, Diluents & Binders
23 Direct Compression
18 Lubricants & Glidants
17 Thickeners and Stabilizers
17 Disintegrants & Superdisintegrants
14 Chewable & Orodispersible Aids
14 Co-Processed Excipients
14 Taste Masking
11 Coating Systems & Additives
11 Parenteral
11 Film Formers & Plasticizers
10 Granulation
8 Empty Capsules
7 Controlled & Modified Release
3 Emulsifying Agents
3 API Stability Enhancers
2 Solubilizers
2 Coloring Agents
2 Rheology Modifiers
1 Topical
1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 62 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
62 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 18 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
18 Finished Drug Prices
10 Annual Reports

MARKET PLACE

7 APIs, 6 FDF Dossiers

7 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

76 US Patents, 3 Health Canada Patents

76 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

7 USP, 7 Others

7 USP
7 Others

$ API Ref.Price (USD/KG) : 680,068 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

7 All

01 11492200

02 11492211

03 11492222

04 11492233

05 11492244

06 11492255

07 11492266

filter Description Reset all filters

7 All

01 1Palonosetron Enantiomer (15 mg) ((3aR)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)

02 1Palonosetron Hydrochloride (100 mg)

03 1Palonosetron Related Compound A (15 mg) ((3aS)-1-Oxo-2-[(3S)-quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline 1-oxide)

04 1Palonosetron Related Compound B (15 mg) ((3S)-3-(1-Oxo-5,6-dihydro-1H-benzo[de]isoquinolin-2(4H)-yl)quinuclidine 1-oxide)

05 1Palonosetron Related Compound C (15 mg) ((3aS)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)

06 1Palonosetron Related Compound D (15 mg) ((3aR)-2-[(3S)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)

07 1Palonosetron Related Compound E (15 mg) (2-[(3S)-Quinuclidin-3-yl]-2,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)

filter CAS Number Reset all filters

7 All

01 11021456-82-5

02 1135729-55-4

03 1135729-62-3

04 1135729-75-8

05 1135729-76-9

06 1135755-51-0

07 1813425-83-1

Product Main Page

01

USP

Pharma Manufacturing 2024

Not Confirmed

USP

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Palonosetron Related Compound E (15 mg) (2-[(...

CAS Number : 135729-55-4

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1492266

Current Lot : F027A0

Previous Lot :

NDC Code :

Product Web Link

Digital Content

02

USP

Pharma Manufacturing 2024

Not Confirmed

USP

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Palonosetron Related Compound D (15 mg) ((3aR...

CAS Number : 135755-51-0

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1492255

Current Lot : F02790

Previous Lot :

NDC Code :

Product Web Link

Digital Content

03

USP

Pharma Manufacturing 2024

Not Confirmed

USP

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Palonosetron Related Compound C (15 mg) ((3aS...

CAS Number : 135729-76-9

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1492244

Current Lot : R08550

Previous Lot : F02780 (30-APR-2018)

NDC Code :

Product Web Link

Digital Content

04

USP

Pharma Manufacturing 2024

Not Confirmed

USP

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Palonosetron Related Compound B (15 mg) ((3S)...

CAS Number : 1021456-82-5

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1492233

Current Lot : F02770

Previous Lot :

NDC Code :

Product Web Link

Digital Content

05

USP

Pharma Manufacturing 2024

Not Confirmed

USP

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Palonosetron Related Compound A (15 mg) ((3aS...

CAS Number : 813425-83-1

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1492222

Current Lot : F02760

Previous Lot :

NDC Code :

Product Web Link

Digital Content

06

USP

Pharma Manufacturing 2024

Not Confirmed

USP

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Palonosetron Enantiomer (15 mg) ((3aR)-2-[(3R...

CAS Number : 135729-75-8

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1492211

Current Lot : F027B0

Previous Lot :

NDC Code :

Product Web Link

Digital Content

07

USP

Pharma Manufacturing 2024

Not Confirmed

USP

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Palonosetron Hydrochloride (100 mg)

CAS Number : 135729-62-3

Quantity Per Vial :

Price ($) : 230

Catalog Number : 1492200

Current Lot : F02750

Previous Lot :

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?